New Technology for Finding and Analyzing Tiny Cell Messengers
Capillary-channeled polymers fibers and films - A platform technology for exosome isolation and analytics
This project is creating a new way to easily collect and study tiny particles called exosomes, which are important for understanding diseases and delivering medicines.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Clemson University NIH-funded |
| Lab location | 1 site (Clemson, United States) |
| Project ID | NIH-11136292 on NIH RePORTER |
What this research studies
Our bodies' cells release tiny packages called exosomes, which carry important information and can tell us a lot about our health and diseases. Currently, it's hard to collect these exosomes cleanly and quickly for study. This project is developing a special material, made of unique polymer fibers and films, that acts like a super-efficient filter to capture exosomes from biological samples. This new method aims to make it much easier and faster for scientists to get the exosomes they need for their work. By improving how we isolate exosomes, we can speed up discoveries in disease diagnosis and new treatments.
Who could benefit from this research
Good fit: This project is focused on developing a laboratory tool, so it does not involve direct patient participation.
Not a fit: Patients will not directly receive treatment or diagnostic services from this foundational technology development.
Why it matters
Potential benefit: If successful, this technology could lead to faster and more accurate disease diagnoses and help develop new ways to deliver medicines directly to where they are needed in the body.
How similar studies have performed: While other methods exist for exosome isolation, this project aims to overcome current limitations by offering a more robust, versatile, and cost-effective approach.
Where this research is happening
Clemson, United States
- Clemson University — Clemson, United States (Active)
Researchers
- Principal investigator: Marcus, Richard Kenneth — Clemson University
- Study coordinator: Marcus, Richard Kenneth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.